Risperidone for disruptive behaviour disorders in children and young people with borderline-to-moderate intellectual disability

This review has been withdrawn.

The reason for withdrawal and previous versions are archived and accessible within the withdrawn record in the Cochrane Library.

Health topics:

Published:

14 January 2021

Authors:

Wiysonge CS, Zunza M, Ngcobo N, Bezuidenhout H

Was this helpful? Donate.

If you found this evidence helpful, please consider donating to Cochrane. We are a charity that produces accessible evidence to help people make health and care decisions.
Donate
Print
PDF
Citation
Wiysonge CS, Zunza M, Ngcobo N, Bezuidenhout H. Risperidone for disruptive behaviour disorders in children and young people with borderline-to-moderate intellectual disability (Protocol). Cochrane Database of Systematic Reviews 2021, Issue 1. Art. No.: CD009988. DOI: 10.1002/14651858.CD009988.pub2.